This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 1982 Jul;222(1):227-31.

Characterization of the antihypertensive properties of ketanserin (R 41 468) in rats

H O Kalkman, P B Timmermans, P A Van Zwieten

PMID: 6283070

Characterization of the antihypertensive properties of ketanserin (R 41 468) in rats

H O Kalkman et al. J Pharmacol Exp Ther. 1982 Jul.

. 1982 Jul;222(1):227-31.

Authors

H O Kalkman, P B Timmermans, P A Van Zwieten

PMID: 6283070

No abstract available

PubMed Disclaimer

Similar articles

Mechanism of antihypertensive action of ketanserin in man.
Reimann IW, Frölich JC. Reimann IW, et al. Br Med J (Clin Res Ed). 1983 Aug 6;287(6389):381-3. doi: 10.1136/bmj.287.6389.381-a. Br Med J (Clin Res Ed). 1983. PMID: 6135489 Free PMC article. Clinical Trial.
Inhibition by intraventricular microinfusion of ketanserin of the cardiovascular responses to peripheral administration of methoxamine in rats.
Mollace V, De Francesco EA, Fersini G, Nisticò G. Mollace V, et al. Funct Neurol. 1991 Apr-Jun;6(2):101-6. Funct Neurol. 1991. PMID: 1655588
Antihypertensive properties of ketanserin (R 41 468).
Vanhoutte PM, Van Nueten JM, Symoens J, Janssen PA. Vanhoutte PM, et al. Fed Proc. 1983 Feb;42(2):182-5. Fed Proc. 1983. PMID: 6295821 Review.
Mechanism of the hypotensive effect of ketanserin.
Fozard JR. Fozard JR. J Cardiovasc Pharmacol. 1982 Sep-Oct;4(5):829-38. doi: 10.1097/00005344-198209000-00020. J Cardiovasc Pharmacol. 1982. PMID: 6182416 No abstract available.
Can peripheral serotonergic blockade explain the hypotensive effect of ketanserin?
Vanhoutte PM. Vanhoutte PM. J Cardiovasc Pharmacol. 1985;7 Suppl 7:S105-9. doi: 10.1097/00005344-198500077-00030. J Cardiovasc Pharmacol. 1985. PMID: 2412025 Review.

See all similar articles

Cited by

In vivo and in vitro activity of selective 5-hydroxytryptamine2 receptor antagonists.
Conolan S, Quinn MJ, Taylor DA. Conolan S, et al. Br J Pharmacol. 1986 Sep;89(1):129-35. doi: 10.1111/j.1476-5381.1986.tb11128.x. Br J Pharmacol. 1986. PMID: 3801767 Free PMC article.
Alpha 1 antagonistic and antiserotoninergic action during administration of ketanserin.
Vermylen J, Fiocchi R, Fagard R, Lijnen P, Staessen J, Amery A. Vermylen J, et al. Br Med J (Clin Res Ed). 1983 Nov 19;287(6404):1551-2. doi: 10.1136/bmj.287.6404.1551-a. Br Med J (Clin Res Ed). 1983. PMID: 6139140 Free PMC article. Clinical Trial. No abstract available.
Platelet-vessel wall interactions in hemostasis: implication of 5-hydroxytryptamine.
De Clerck F, Somers Y, Van Gorp L. De Clerck F, et al. Agents Actions. 1984 Dec;15(5-6):627-35. doi: 10.1007/BF01966784. Agents Actions. 1984. PMID: 6543415
Ketanserin without effects on basal anterior pituitary hormone secretion in healthy subjects.
Gordin A, Mustajoki P, Pelkonen R. Gordin A, et al. J Endocrinol Invest. 1985 Feb;8(1):73-5. doi: 10.1007/BF03350647. J Endocrinol Invest. 1985. PMID: 2985688
Antihypertensive effects of chronic 5-hydroxytryptamine (5-HT2) receptor blockade with irindalone in the spontaneously hypertensive rat.
Gradin K, Hedner T, Persson B. Gradin K, et al. J Neural Transm Gen Sect. 1991;83(3):227-33. doi: 10.1007/BF01253392. J Neural Transm Gen Sect. 1991. PMID: 1674420

See all "Cited by" articles

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Other Literature Sources
- The Lens - Patent Citations Database
Medical
- MedlinePlus Health Information